Today, we stand together from Amsterdam to Nairobi to Buenos Aires to New York to Bangkok and raise our collective voices that will not be silenced to loudly clamour for an end to repression and punishment as instruments of drug control.
The Global Commission on Drug Policy analyze the last thirty years of over-incarceration in closed settings, from prisons to migrant administrative detention and from mandatory treatment to private rehabilitation centers.
The World Health Organization highlights the current landscape of country hepatitis policies for harm reduction and HCV testing and treatment in PWID and people in prisons.
The World Drug Report will be launched during a Special Event of the Commission on Narcotic Drugs (CND) on the International Day against Drug Abuse and Illicit Trafficking, chaired by Ambassador Mirghani Abbaker Altayeb Bakhet, Chair of the 62nd session of the CND.
The issue of the medical use of cannabis is one in which the Board has failed to match the progress it has made in certain other areas, such as the death penalty. Its position on the therapeutic applications of cannabis remains as it was at the close of the UNGASS decade; indeed, if anything, it…
IDPC, CELS, HRI and MUCD note persistent human rights violations committed in the name of drug control and suggest recommendations for the OHCHR and the HRC to address them.
The 2019 Ministerial Segment laid bare some of the frictions at the heart of the international consensus on drug policy, also highlighting pending tasks.
Mr de Joncheere is a Dutch citizen and has expertise in pharmacy and health sciences. He was previously Director of the Department of Essential Medicines and Health Products at the World Health Organization.
We are looking to appoint a Team Assistant to contribute to the smooth running of our secretariat operations based in London, and to provide essential administrative and accounting support to a small but dynamic and busy team. Apply before 6th June!
The INCB's participation at CND showed how far the Board has come in terms of supporting human rights norms in the pursuit of drug control obligations, but the Board's outdated inflexibility on cannabis is regrettable.
